SSS

Sonnet BioTherapeutics Holdings, Inc.

No trades
See on Supercharts

SONN fundamentals

Sonnet BioTherapeutics Holdings, Inc. earnings per share and revenue

SONN earnings per share for the last quarter are -5.60 USD whereas the estimation was -6.12 USD which accounts for 8.50% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 28.50 k USD. Estimated earnings per share for the next quarter are -5.04 USD, and revenue is expected to reach 28.00 k USD. Also watch annual changes over time to get a bigger picture of SONN earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise